Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 3395-3399, September 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svingen, B. A.
Right arrow Articles by Scott, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svingen, B. A.
Right arrow Articles by Scott, M.

Protection against Adriamycin-induced Skin Necrosis in the Rat by Dimethyl Sulfoxide and {alpha}-Tocopherol1

Bruce A. Svingen, Garth Powis2, Peggy L. Appel and Mark Scott

Division of Developmental Oncology Research, Mayo Clinic, Rochester, Minnesota 55905

Extravasation of Adriamycin during i.v. infusion can cause serious local complications. We have used a rat skin model to study the protection afforded by dimethyl sulfoxide and {alpha}-tocopherol (vitamin E) against Adriamycin-induced skin necrosis. Topical daily application of 1 ml dimethyl sulfoxide for 2 days produced a small decrease in ulcer diameter of up to 11% at 2 weeks. Topical daily applications of 1 ml 10% {alpha}-tocopherol succinate in dimethyl sulfoxide for 2 days produced a marked decrease in ulcer diameter at 2 weeks of up to 68%. Daily topical application of 1 ml 10% {alpha}-tocopherol succinate in dimethyl sulfoxide for 7 days offered no greater protection than 2-day application. {alpha}-Tocopherol acetate appeared to have activity slightly less than that of {alpha}-tocopherol succinate in reducing ulcer size, and both compounds were considerably more active than was {alpha}-tocopherol alcohol. Administration of {alpha}-tocopherol succinate or {alpha}-tocopherol acetate i.p. had no significant effect upon ulcer diameter. Topically applied dimethyl sulfoxide and {alpha}-tocopherol may provide an effective way of treating accidentally extravasated Adriamycin in cancer patients.

1 This work was supported by Grant CA 25337, awarded by NIH, Department of Health, Education, and Welfare, and American Cancer Society Grant CH 143.

2 To whom requests for reprints should be addressed.

Received 2/11/81. Accepted 6/ 8/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.